Pharma company Lupin Limited has seen gains in share price on its June quarter performance. While operating profit margins shrunk slightly QoQ, it was still strong compared to the same quarter last year - at 19.47% compared to 13.6% in the same quarter last year. Also see Lupin's F&O performance.
One of Lupin's significant shareholders, investor Rakesh Jhunjhunwala, has cut his stake recently in the stock, but still holds a large percentage at 1.7% compared to 1.9% in the previous quarter. FII+DII holding in Lupin rose in the June quarter.